Chemical Compound

GSK1904529A

CAS Registry Number 1089283-49-7
GSK1904529A chemical structure
Primary Record

GSK1904529A

In stock
8,727 g
Purity
99.5 %
CAS
1089283-49-7

Compound Identifiers & Properties

CAS
1089283-49-7
PubChem CID
25124816
SMILES
CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F
Canonical SMILES
CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1

Names & Synonyms

  • GSK1904529A
  • 1089283-49-7
  • GSK-1904529A
  • RefChem:1090882
  • cc-35
  • CHEMBL466397
  • GSK 1904529A
  • MLS006010966
  • SCHEMBL309890
  • DTXSID70648776
  • MOSKATHMXWSZTQ-UHFFFAOYSA-N
  • orb1689845
  • C44H47F2N9O5S
  • IGF-1R inhibitor GS1904529A
  • SCHEMBL29391496
  • CHEBI:91401
  • DTXCID60599526
  • EX-A008
  • GDC0941
  • GSK4529
  • MFCD17010271
  • GLXC-90198
  • HMS3295G13
  • HMS3654G19
  • AMY24202
  • AOB87389
  • GSK 4529
  • ABP000158
  • BDBM50256480
  • NSC767951
  • s1093
  • AKOS030238962
  • ZINC150338709
  • CCG-264817
  • CS-0044
  • EX-8674
  • FG65035
  • GSK1904529
  • NSC-767951
  • QC-7246
  • RL00381
  • SB19376
  • SDCCGSBI-0654441.P001
  • NCGC00253439-01
  • NCGC00253439-04
  • AC-28459
  • AK546985
  • AN-16807
  • AS-17030
  • BC622985
  • HY-10524
  • N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
  • SMR004702770
  • AB0035855
  • A1302
  • FT-0733738
  • SW219610-1
  • Y0282
  • EC-000.2336
  • GSK 1904529A (GSK 4529)
  • A10440
  • A24618
  • S-7674
  • BRD-K04833372-001-01-3
  • BRD-K04833372-001-06-2
  • Q27163259
  • N-(2,6-difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
  • N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
  • N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide
  • N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-
  • N-(2,6-difluorophenyl)-5-{3-[2-({5-ethyl-4-[4-(4-methanesulfonylpiperazin-1-yl)piperidin-1-yl]-2-methoxyphenyl}amino)pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl}-2-methoxybenzamide
  • GSK 4529; N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
  • N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
  • N-(2,6-Difluorophenyl)-5-(3-(2-(5-ethyl-4-(4-(4-(methanesulfonyl)piperazin-1-yl)piperidin-1-yl)-2-methoxyanilino)pyrimidin-4-yl)imidazo(1,2-a)pyridin-2-yl)-2-methoxybenzamide
  • N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide
  • N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamide
  • N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)-1-piperidyl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxy-benzamide
  • N-(2,6-Difluorophenyl)-5-{3-[2-(5-ethyl-4-{4-[4-(methanesulfonyl)piperazin-1-yl]piperidin-1-yl}-2-methoxyanilino)pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl}-2-methoxybenzamide